2023
DOI: 10.1016/j.cellsig.2023.110913
|View full text |Cite
|
Sign up to set email alerts
|

Phosphorylated Hsp27 promotes adriamycin resistance in breast cancer cells through regulating dual phosphorylation of c-Myc

Xiaowen Bi,
Miao Zhang,
Jinyi Zhou
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 56 publications
0
3
0
Order By: Relevance
“…The overexpression of Hsp27 in AS-B145 or BT-474 breast cancer cells diminished the inhibitory effect of ovatodiolide on mammosphere formation [26], while the phosphorylation of Hsp27 at Ser15 promoted its Ser78 phosphorylation and enhanced the nuclear localization of HER2 to induce Trastuzumab (TZMB) resistance in HER2 + breast cancer cells [27]. Hsp27-overexpressing KT breast cancer cells showed increased resistance to ultraviolet ray C (UVC) and interferon lethality [28], and our recent study also found that phosphorylated Hsp27 promoted ADR resistance in MCF-7 and MDA-MB-231 breast cancer cells by regulating DNA damage repair protein c-Myc dual phosphorylation [29]. A proposed model of Hsp27 in breast cancer development is illustrated in Figure 2.…”
Section: Hsp27mentioning
confidence: 90%
“…The overexpression of Hsp27 in AS-B145 or BT-474 breast cancer cells diminished the inhibitory effect of ovatodiolide on mammosphere formation [26], while the phosphorylation of Hsp27 at Ser15 promoted its Ser78 phosphorylation and enhanced the nuclear localization of HER2 to induce Trastuzumab (TZMB) resistance in HER2 + breast cancer cells [27]. Hsp27-overexpressing KT breast cancer cells showed increased resistance to ultraviolet ray C (UVC) and interferon lethality [28], and our recent study also found that phosphorylated Hsp27 promoted ADR resistance in MCF-7 and MDA-MB-231 breast cancer cells by regulating DNA damage repair protein c-Myc dual phosphorylation [29]. A proposed model of Hsp27 in breast cancer development is illustrated in Figure 2.…”
Section: Hsp27mentioning
confidence: 90%
“…A recent study on MCF7 breast cancer cells gave consistent results and provided new insight. Bi et al [81] have shown that the phosphorylation of Hsp27 preceded by exposure to DOX led to the upregulation of c-Myc in the nucleus, causing ataxiatelangiectasia mutated (ATM) kinase activation and which further negatively affected p53 (Figure 2).…”
Section: Hsp27 Mediates Resistance To a Wide Range Of Chemotherapeuticsmentioning
confidence: 99%
“…A recent study on MCF7 breast cancer cells gave consistent results and provided new insight. Bi et al [81] have shown that the phosphorylation of Hsp27 preceded by exposure to DOX led to the upregulation of c-Myc in the nucleus, causing ataxiatelangiectasia mutated (ATM) kinase activation and which further negatively affected p53 (Figure 2). Another agent in the resistance to which Hsp27 has been found implicated is trastuzumab, also known as herceptin, a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2), which is overexpressed in up to 30% of invasive breast cancer cases and also in some gastric cancer subtypes.…”
Section: Hsp27 Mediates Resistance To a Wide Range Of Chemotherapeuticsmentioning
confidence: 99%